Michael L Schilsky
Overview
Explore the profile of Michael L Schilsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
3050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marino Z, Schilsky M
Semin Liver Dis
. 2024 Nov;
PMID: 39496313
The Wilson disease (WD) research field is rapidly evolving, and new diagnostic and therapeutical approaches are expected to be change-gamers in the disease for the incoming years, after decades of...
2.
Ott P, Sandahl T, Ala A, Cassiman D, Couchonnal-Bedoya E, Cury R, et al.
JHEP Rep
. 2024 Aug;
6(8):101115.
PMID: 39139457
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges...
3.
Harrington C, Carpenter G, Coverdale J, Douglas L, Mills C, Willis K, et al.
Clin Chem Lab Med
. 2024 Jul;
PMID: 39072400
Objectives: Assessment of Wilson disease is complicated, with neither ceruloplasmin, nor serum or urine copper, being reliable. Two new indices, accurate non-ceruloplasmin copper (ANCC) and relative ANCC were developed and...
4.
Schilsky M, Emre S
Clin Liver Dis (Hoboken)
. 2024 Jul;
23(1):e0244.
PMID: 38952697
No abstract available.
5.
Coskun A, Aydin A, Tosun S, To U, Rubman S, Schilsky M, et al.
Front Psychol
. 2024 May;
15:1326802.
PMID: 38803830
Introduction: The COVID-19 pandemic significantly impacted the mental health of individuals with chronic conditions such as Wilson's Disease (WD). This study investigates stress, anxiety, depression, quality of life, cognitive function,...
6.
Teicher Kirk F, Munk D, Swenson E, Quicquaro A, Holm Vendelbo M, Schilsky M, et al.
Hepatology
. 2023 Dec;
79(5):1065-1074.
PMID: 38088886
Background And Aims: Trientine (TRI) and D-penicillamine (PEN) are used to treat copper overload in Wilson disease. Their main mode of action is thought to be through the facilitation of...
7.
Teicher Kirk F, Munk D, Swenson E, Quicquaro A, Holm Vendelbo M, Larsen A, et al.
J Hepatol
. 2023 Dec;
80(4):586-595.
PMID: 38081365
Background & Aims: In Wilson disease (WD), copper accumulates in the liver and brain causing disease. Bis-choline tetrathiomolybdate (TTM) is a potent copper chelator that may be associated with a...
8.
Roberts E, Schilsky M
N Engl J Med
. 2023 Sep;
389(10):922-938.
PMID: 37672695
No abstract available.
9.
Camarata M, Ala A, Coskun A, Deng Y, Embel V, Gonzalez-Peralta R, et al.
J Acad Consult Liaison Psychiatry
. 2022 Dec;
64(2):106-117.
PMID: 36521682
Background And Aims: Psychiatric symptoms are frequently reported in Wilson disease (WD); however, systematic assessments with validated measures are lacking. Objective: We aim to report the prevalence and clinical correlates...
10.
Schilsky M, Czlonkowska A, Zuin M, Cassiman D, Twardowschy C, Poujois A, et al.
Lancet Gastroenterol Hepatol
. 2022 Oct;
7(12):1092-1102.
PMID: 36183738
Background: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to...